Irhythm Technologies, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
iRhythm Holdings, Inc. reported a 26% increase in revenue and a significantly reduced net loss for 2025, while navigating multiple ongoing legal and regulatory challenges.
NASDAQ
iRhythm Technologies' 2024 10-K filing details the company's financial performance, strategic initiatives, and risk factors, highlighting its focus on cardiac monitoring solutions.
NASDAQ
iRhythm Technologies' 2023 annual report reveals a 20% revenue increase alongside ongoing challenges in reimbursement and regulatory compliance.